Benefit of double‐reading cytology smears as a triage strategy among high‐risk human papillomavirus–positive women in Mexico-Reference-Cited by-同舟云学术

Benefit of double‐reading cytology smears as a triage strategy among high‐risk human papillomavirus–positive women in Mexico

Published:2020-06-10 Issue:10 Volume:128 Page:715-724
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathol

Author:

Ramírez‐Palacios Paula¹^ORCID,Chen Aiyu²,Flores Yvonne N.¹³⁴^ORCID,Crespi Catherine M.²⁴^ORCID,Lazcano‐Ponce Eduardo⁵,Alvarez‐Escobedo Daniel⁶,Torres‐Ibarra Leticia⁵,Rivera‐Paredez Berenice⁵⁷,León‐Maldonado Leith⁸^ORCID,Hernández‐López Rubí⁵⁷,Mendiola‐Pastrana Indira R.⁵⁷^ORCID,Méndez‐Hernández Pablo⁹¹⁰^ORCID,Cuzick Jack¹¹,Carmona Enrique¹²,Figueroa Héctor¹³,Montiel‐Cordero Fernando¹⁴,Meneses‐León Joacim⁵⁷^ORCID,Rao Jianyu¹⁵,Salmerón Jorge⁵⁷^ORCID,

Affiliation:

1. Unidad de Investigación Epidemiológica y en Servicios de Salud, Delegación Morelos Instituto Mexicano del Seguro Social Cuernavaca Mexico

2. Department of Biostatistics Fielding School of Public Health University of California Los Angeles California

3. Department of Health Policy and Management and Kaiser Permanente Center for Health Equity Fielding School of Public Health University of California Los Angeles California

4. UCLA Cancer Prevention and Control Research Center, Fielding School of Public Health and Jonsson Comprehensive Cancer Center University of California Los Angeles California

5. Centro de Investigación en Salud Poblacional. Instituto Nacional de Salud Pública Cuernavaca Mexico

6. Unidad de Medicina Familiar, Hospital General Regional No. 1 Instituto Mexicano del Seguro Social Cuernavaca Mexico

7. Centro de Investigación en Políticas, Población y Salud, Facultad de Medicina Universidad Nacional Autónoma de México Mexico City Mexico

8. Cátedra CONACYT‐Instituto Nacional de Salud Pública Cuernavaca Mexico

9. Departamento de Calidad y Educación en Salud Secretaria de Salud Tlaxcala Santa Ana Chiautempan Mexico

10. Facultad de Ciencias de la Salud Universidad Autónoma de Tlaxcala Zacatelco Mexico

11. Wolfson Institute of Preventive Medicine Centre for Cancer Prevention Queen Mary University of London London United Kingdom

12. Laboratorio CITOMED Cuernavaca México

13. Laboratorio de Citología Laboratorio Estatal de Salud Pública Tlaxcala México

14. Hospital de la Mujer de Tlaxcala Tlaxcala México

15. Department of Pathology and Laboratory Medicine University of California Los Angeles California

Funder

Secretaría de Salud

Bracco Diagnostics

UCLA Chicano Studies Research Center

Roche

Consejo Nacional de Ciencia y Tecnología

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncy.22303

Reference41 articles.

1. Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices

2. World Health Organization.Cervical cancer. Accessed May 28 2020.https://www.who.int/cancer/prevention/diagnosis‐screening/cervical‐cancer/en/

3. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

4. BruniL AlberoG SerranoB et al.ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 17 June2019. Accessed on May 28 2020.https://www.hpvcentre.net/statistics/reports/XWX.pdf

5. TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMES

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico;Cancers;2024-07-08

2. Performance of urine samples compared to cervical samples for detection of precancer lesions among HPV-positive women attending colposcopy clinic in Mexico City;Cancer Causes & Control;2024-02-18

3. Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries (Review);Oncology Letters;2022-02-09

4. Adjunctive testing by cytology, p16/Ki‐67 dual‐stained cytology or HPV16/18 E6 oncoprotein for the management of HPV16/18 screen‐positive women;International Journal of Cancer;2020-12-22